During the deadly virus outbreak, the company claimed its anti-virus activewear had been sprayed with a substance called “LJ Shield”, which protected people against pathogens.
Advertisements on the brand’s website, stores and Instagram used the tag “Cure for the Spread of COVID-19? Lorna Jane Thinks So”.
The Australian Competition and Consumer Commission (ACCC) launched court action against Lorna Jane for allegedly making false and misleading claims.
In a decision delivered in the Federal Court on Friday, Justice Darryl Rangiah said Lorna Jane sought to “exploit the fear and concern” surrounding the deadly outbreak.
“The advertising campaign was conducted in July 2020, at a time of considerable uncertainty, fear and concern amongst the public about the consequences and spread of COVID-19,” he said.
“Lorna Jane sought to exploit that fear and concern of the public through the use of misleading deceptive and untrue representations about the properties of LJ Shield activewear.
“Lorna Jane sought to profit from the fear with concerns of the public in a way that involves unlawful conduct in contravention of the relevant provisions of the Australian Consumer Law.
“The behaviour of Lorna Jane can only be described as exploitative, predatory and potentially dangerous.”
Justice Rangiah said the court must impose a substantial penalty to reflect the conduct’s seriousness and demonstrate “exploitative conduct of this kind will not pay”.
He found it had not been shown the company had actually profited from its conduct and said the $5 million fine agreed by both parties on the eve of the hearing to be appropriate.
ACCC commissioner Sarah Court previously said it was “particularly concerning”, with the company giving the impression the COVID-19 claims were based on scientific or technological evidence.
“We are particularly concerned about this because consumers often trust well-known brands and assume that their marketing claims are backed up by solid evidence.”
In July last year, Lorna Jane copped an almost $40,000 fine from the Therapeutic Goods Administration for failing to seek correct approval for the ads.
Action against company director Lorna Jane Clarkson for being “knowingly concerned” in the conduct did not proceed.
Lorna Jane has 108 stores in Australia, plus several overseas, including in the USA and New Zealand.Jump to next article